INNATE PHARMA: cashflow_operating
| Value | {"amount": -32559000.0, "concept": "ifrs-full:CashFlowsFromUsedInOperatingActivities"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | superseded |
| Entity | INNATE PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T23:19:24.905918+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/7dcf9a3b-9f9b-47c2-8196-e6b404ed3c45
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:9695002Y8420ZB8HJE29:2024-12-31Retrieved: 2026-08-23T23:19:24.905918+02:00
Raw response sha256:
c477e47ed4a27d7e67bbe48f2d843a4d…Cite as: FACTANKER, https://factanker.com/fact/7dcf9a3b-9f9b-47c2-8196-e6b404ed3c45
History
- no predecessors — first report